Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS
Clinical trial NCT03800524 · UNKNOWN
Trial details
- NCT number
- NCT03800524
- Sponsor
- Humanitas Mirasole SpA
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2023-12-31
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.